Citation Tools

Download PDFPDF

Original research
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146

Download to a citation manager

Cite this article as:
Makker V, Taylor MH, Aghajanian C, et al
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146